Clinical Laboratory Services Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 277.96 Billion |
| Market Size (2029) | USD 380.65 Billion |
| CAGR (2024 - 2029) | 6.49 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Clinical Laboratory Services Market Analysis
The Clinical Laboratory Services Market size is estimated at USD 277.96 billion in 2024, and is expected to reach USD 380.65 billion by 2029, growing at a CAGR of 6.49% during the forecast period (2024-2029).
The COVID-19 pandemic impacted the clinical laboratory services market positively. Clinical diagnostics and technology, including molecular and serological testing for severe COVID-19 infections, increased globally during the pandemic. There was also an increase in rapid and widespread testing developments through improvements in clinical diagnostics and testing technology that helped increase the overall demand. For instance, in February 2021, Thermo Fisher Scientific launched the TaqPath COVID-19 HT Kit, which is for use on its automated amplitude platform, to increase its COVID-19 testing capacity by combining Thermo Fisher's extraction and real-time PCR instruments with liquid handling products from Tecan Group.
It has been observed that clinical laboratory services were largely used during the COVID-19 pandemic, which contributed to the growth of the market studied. Currently, the market studied has reached its pre-pandemic nature in terms of demand for services. It is expected that it will witness healthy growth shortly.
The rising incidence of chronic and infectious diseases and the increasing demand for accurate and early disease diagnosis techniques drive the market. The burden of infectious diseases and chronic disorders is constantly growing worldwide. As clinical diagnostic tests represent one of the most accurate methods for identifying and characterizing various biomarkers of chronic diseases and for detecting microorganisms, their demand is increasing with the rising burden of diseases such as cancer and tuberculosis (TB). For instance, according to an update from the WHO, about 10 million people globally had tuberculosis as of 2021, of which 5.6 million were men, 3.3 million were women, and 1.1 million were children. Due to the high burden of such diseases, the demand for clinical services is expected to increase, driving the growth of the market studied.
The growing burden of cancer is also expected to boost the demand for clinical diagnostics. For instance, according to Globocan Statistics 2020, there were 19.3 million new cases of cancer all over the world, accounting for both sexes, and the same source reported that the incidence of cancer is growing at a rapid pace globally. It is estimated that the number of new cancer cases in both sexes will reach 30.2 million by 2040.
Hence, owing to the increased burden of target diseases, market players are focusing on technological advancements for their products to have a competitive edge over the other players, which is expected to augment the growth of the market studied further. For instance, in July 2022, SRL Diagnostics launched the Fatty Liver Index for the diagnosis of non-alcoholic fatty liver disease. Thus, the launch of technologically advanced products, coupled with increased awareness about the early diagnosis of diseases, is anticipated to drive growth in the clinical laboratory services market.
However, stringent regulatory issues in various countries and the lack of skilled laborers are expected to restrain the market growth during the forecast period.
Clinical Laboratory Services Market Trends
Independent and Reference Laboratories Segment is Expected to Register Healthy Growth Over the Forecast Period
In highly populated and developing countries like India and China, where a significant share of the population does not have access to proper medical diagnostic facilities, there is a huge opportunity for independent laboratories to thrive in the market studied, as they can fill the wide gap of clinical service providers in these regions. Hence, the number of independent laboratories is increasing. For instance, according to the National Accreditation Board for Testing and Calibration Laboratories (NABL) of India, around 6,200 NABL-accredited medical labs were present, which increased to 6,975 by March 2022 owing to the surge in demand for these facilities all over the country.
The independent laboratory segment is experiencing huge consolidation as players focus on strategic partnerships and collaborations, which are likely to drive the market's growth. For instance, in November 2022, GC Labs signed a new contract with a global partner in Thailand, marking its ongoing commitment to building a strong diagnostics network in Southeast Asia. With this partnership, GC labs planned to expand its market share across Southeast Asia. Therefore, all these developments are fueling growth in the segment studied as well as the overall clinical laboratory services market.
North America is Expected to Dominate the Clinical Laboratory Services Market Over the Forecast Period
The major factor driving the growth of the North American clinical laboratory services market is the presence of key players and government organizations in the country, which creates awareness among the general population and allows them to access services conveniently. For instance, the American Clinical Laboratory Association is a not-for-profit organization that offers members the benefits of representation, education, information, and research.
The high burden of the target and chronic diseases in the region and increasing demand for early diagnostics are the other major factors that are driving the growth of the market studied in the North American region. For instance, according to the Canadian Cancer Society's 2021 report, about 229,200 new cancer cases were diagnosed in Canada in 2021. On average, 628 Canadians are diagnosed with cancer every day, which is further expected to increase in the future. Also, as per the same report, lung, breast, colorectal, and prostate cancer are the most diagnosed types of cancer in Canada (excluding non-melanoma skin cancer).
Further, with the COVID-19 pandemic, many established and new players in the market expanded their diagnostics capacity owing to the huge surge in demand, augmenting the growth of the market studied in the region. For instance, in February 2021, Omega Corporation announced the expansion of its clinical laboratory operations in Canada with the launch of a polymerase chain reaction test to detect all variants of COVID-19.
The presence of key market players in the country, acquisitions, and partnerships, along with the new launches, are further expected to complement the growth of the clinical laboratory services market in the country. For instance, in August 2022, Labcorp, a leading global life sciences company, announced that it had closed the acquisition of RWJBarnabas Health's outreach laboratory business and select related assets. RWJBarnabas Health is New Jersey's largest academic health system. Therefore, due to the above-mentioned factors, the North American region is expected to hold a major market share in the market studied over the forecast period of the study.
Clinical Laboratory Services Industry Overview
The market for clinical laboratory services is highly competitive, and various global and local companies are present in the market. A major share of the market is grabbed by the global players, and local companies are also focusing on delivering innovative services to the people, which is allowing these companies to establish their considerable place in this market. With a rising need for technology, it is expected that few new entrants will be seen in the market in the future, and these players will gain a substantial share. Some of the major players in the market include LabCorp and Quest Diagnostics.
Clinical Laboratory Services Market Leaders
-
OPKO Health Inc.
-
Quest Diagnostics Incorporated
-
LabCorp
-
NeoGenomics
-
Myriad Genetics, Inc.
*Disclaimer: Major Players sorted in no particular order
Clinical Laboratory Services Market News
- September 2022: Bionano Genomics Inc. announced the launch of Bionano Laboratories, a new organization that combines Bionano's optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen. It also announced the launch of Bionano Laboratories' first OGM-based laboratory-developed test (LDT).
- March 2022: Mindray launched its latest BC-700 Series hematology analyzers for small-to-midsize labs that incorporate both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests.
- September 2021: The Indian division of Roche Diagnostics launched the Cobas pure integrated solutions analyzer with a more intelligent system suitable for many labs and hospitals operating in the country.
Clinical Laboratory Services Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Technological Advancements in Clinical Testing
- 4.2.2 Rising Burden of Target Diseases and Growing Demand for Early Detection
-
4.3 Market Restraints
- 4.3.1 Regulatory Issues
- 4.3.2 Lack of Skilled Professionals
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Test Type
- 5.1.1 Clinical Chemistry
- 5.1.2 Immunology
- 5.1.3 Cytology
- 5.1.4 Genetics
- 5.1.5 Microbiology
- 5.1.6 Hematology
- 5.1.7 Other Test Types
-
5.2 By Service Provider
- 5.2.1 Hospital-based Laboratories and Others
- 5.2.2 Independent Laboratories
- 5.2.3 Other Service Providers
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Charles River Laboratories
- 6.1.2 Fresenius Medical Care
- 6.1.3 Illumina Inc.
- 6.1.4 Laboratory Corporation of America Holdings (LabCorp)
- 6.1.5 NeoGenomics Laboratories
- 6.1.6 Quest Diagnostics Incorporated
- 6.1.7 OPKO Health
- 6.1.8 Myriad Genetics Inc.
- 6.1.9 Eurofins Scientific
- 6.1.10 Sonic Healthcare Limited
- 6.1.11 Cerba HealthCare
- 6.1.12 SYNLAB International GmbH
- 6.1.13 A.P Moller Holding (Unilabs)
- 6.1.14 Enzo Clinical Labs
- 6.1.15 Genova Diagnostics
- 6.1.16 H.U. Group Holdings Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityClinical Laboratory Services Industry Segmentation
In a clinical laboratory, clinical pathology tests are carried out on collected clinical specimens to obtain information about the patient's health in order to aid in the diagnosis, prevention, and treatment of diseases.
The clinical laboratory services market has been segmented by test type (clinical chemistry, immunology, cytology, genetics, microbiology, hematology, and other test types), service provider (hospital-based laboratories and others, independent laboratories, and other service providers), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value in USD million for the abovementioned segments.
| By Test Type | Clinical Chemistry | |
| Immunology | ||
| Cytology | ||
| Genetics | ||
| Microbiology | ||
| Hematology | ||
| Other Test Types | ||
| By Service Provider | Hospital-based Laboratories and Others | |
| Independent Laboratories | ||
| Other Service Providers | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Clinical Laboratory Services Market Research FAQs
How big is the Clinical Laboratory Services Market?
The Clinical Laboratory Services Market size is expected to reach USD 277.96 billion in 2024 and grow at a CAGR of 6.49% to reach USD 380.65 billion by 2029.
What is the current Clinical Laboratory Services Market size?
In 2024, the Clinical Laboratory Services Market size is expected to reach USD 277.96 billion.
Who are the key players in Clinical Laboratory Services Market?
OPKO Health Inc., Quest Diagnostics Incorporated, LabCorp, NeoGenomics and Myriad Genetics, Inc. are the major companies operating in the Clinical Laboratory Services Market.
Which is the fastest growing region in Clinical Laboratory Services Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Clinical Laboratory Services Market?
In 2024, the North America accounts for the largest market share in Clinical Laboratory Services Market.
What years does this Clinical Laboratory Services Market cover, and what was the market size in 2023?
In 2023, the Clinical Laboratory Services Market size was estimated at USD 259.92 billion. The report covers the Clinical Laboratory Services Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Clinical Laboratory Services Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Which emerging markets offer the biggest growth potential for clinical lab services?
Asia Pacific & Latin America, fueled by rising healthcare spending & aging populations are the emerging markets offering the biggest growth potential for clinical lab services.
Clinical Laboratory Services Industry Report
The global clinical laboratory services market is experiencing significant market growth, driven by the rising prevalence of chronic and infectious diseases and the increasing demand for early and precise disease diagnostics. Technological advancements in clinical diagnostic techniques and a strong emphasis on research and development are propelling the market forward. Independent and reference laboratories are seeing heightened demand in developing regions that lack medical diagnostic facilities. North America leads the global market due to its advanced healthcare infrastructure and the presence of major market players.
The clinical chemistry segment is at the forefront, offering essential tests for disease diagnosis and benefiting from the adoption of digital pathology platforms and comprehensive health checkups. However, the market faces challenges such as regulatory hurdles and a shortage of skilled professionals, which may impede its growth. The market size and market trends indicate a positive outlook, with industry analysis showing robust growth rate.
Industry reports suggest that the market segmentation includes various test types such as clinical chemistry, immunology, and microbiology, among others. The market forecast predicts continued expansion, driven by the increasing demand for diagnostic services. The market overview highlights the competitive landscape, with companies leveraging technological innovations, strategic partnerships, and expansions to maintain their market share.
In conclusion, the clinical laboratory services market is poised for substantial growth, supported by market data and industry statistics. The market review and market predictions underscore the importance of ongoing advancements and the adoption of new technologies in driving market value. Industry research and market leaders are expected to play a crucial role in shaping the future of this dynamic market.
